Total Payments
$8,542
2024 Payments
$817.38
Companies
34
Transactions
498
Medicare Patients
5,370
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$7,926 (92.8%)
Education$616.13 (7.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,926 | 483 | 92.8% |
| Education | $616.13 | 15 | 7.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,504 | 120 | $0 (2023) |
| ViiV Healthcare Company | $1,496 | 90 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,345 | 83 | $0 (2024) |
| Gilead Sciences, Inc. | $925.71 | 54 | $0 (2024) |
| Janssen Products, LP | $488.88 | 6 | $0 (2021) |
| Theratechnologies Inc. | $465.87 | 31 | $0 (2024) |
| Insmed, Inc. | $408.84 | 24 | $0 (2024) |
| MAYNE PHARMA INC. | $176.53 | 11 | $0 (2020) |
| Allergan, Inc. | $176.17 | 10 | $0 (2020) |
| Abbott Laboratories | $157.46 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $817.38 | 43 | ViiV Healthcare Company ($217.33) |
| 2023 | $727.94 | 40 | Merck Sharp & Dohme LLC ($171.99) |
| 2022 | $914.35 | 49 | Janssen Biotech, Inc. ($235.40) |
| 2021 | $902.19 | 48 | Janssen Biotech, Inc. ($432.16) |
| 2020 | $1,466 | 90 | Janssen Biotech, Inc. ($381.96) |
| 2019 | $1,677 | 116 | ViiV Healthcare Company ($365.19) |
| 2018 | $1,351 | 84 | ViiV Healthcare Company ($233.54) |
| 2017 | $686.12 | 28 | Abbott Laboratories ($157.46) |
All Payment Transactions
498 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.87 | General |
| 11/21/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Food and Beverage | In-kind items and services | $30.96 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/20/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: HIV | ||||||
| 11/20/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: HIV | ||||||
| 11/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.48 | General |
| 11/04/2024 | Smith+Nephew, Inc. | RENASYS TOUCH (Device) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Negative Pressure Wound Therapy | ||||||
| 10/30/2024 | Acera Surgical, Inc. | Restrata Wound Matrix (Device) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: Wound Care | ||||||
| 10/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.49 | General |
| 09/19/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: HIV | ||||||
| 08/20/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: HIV | ||||||
| 08/20/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: ANTIBIOTIC | ||||||
| 08/20/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Respiratory | ||||||
| 08/20/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: HIV | ||||||
| 08/15/2024 | Merck Sharp & Dohme LLC | DELSTRIGO (Drug) | Food and Beverage | In-kind items and services | $31.01 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/01/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: HIV | ||||||
| 07/18/2024 | Merck Sharp & Dohme LLC | DELSTRIGO (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/17/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: HIV | ||||||
| 07/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.16 | General |
| 07/15/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: HIV | ||||||
| 06/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.20 | General |
| 06/24/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: HIV | ||||||
| 06/20/2024 | Merck Sharp & Dohme LLC | DELSTRIGO (Drug) | Food and Beverage | In-kind items and services | $31.87 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/20/2024 | Merck Sharp & Dohme LLC | DELSTRIGO (Drug) | Education | In-kind items and services | $10.85 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/03/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,309 | 3,956 | $682,262 | $270,642 |
| 2022 | 12 | 1,302 | 4,411 | $730,154 | $277,402 |
| 2021 | 12 | 1,288 | 4,111 | $697,268 | $269,063 |
| 2020 | 11 | 1,471 | 3,699 | $659,206 | $252,835 |
Total Patients
5,370
Total Services
16,177
Medicare Billing
$1.1M
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 338 | 2,200 | $321,200 | $133,180 | 41.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 132 | 563 | $78,257 | $30,027 | 38.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 116 | 245 | $51,205 | $22,177 | 43.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 192 | 219 | $60,882 | $21,658 | 35.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 135 | 160 | $65,440 | $20,712 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 103 | 224 | $32,928 | $14,765 | 44.8% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 111 | 131 | $34,977 | $12,466 | 35.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 57 | $12,369 | $5,362 | 43.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 42 | 42 | $9,114 | $3,583 | 39.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 57 | 78 | $6,552 | $3,227 | 49.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $5,678 | $2,025 | 35.7% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 15 | 20 | $3,660 | $1,461 | 39.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 360 | 2,818 | $411,428 | $154,611 | 37.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 275 | 318 | $88,404 | $32,085 | 36.3% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 121 | 502 | $69,778 | $26,401 | 37.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 103 | 214 | $31,458 | $14,496 | 46.1% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 111 | 123 | $32,841 | $11,940 | 36.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 71 | 79 | $32,311 | $11,897 | 36.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 64 | 104 | $21,736 | $8,182 | 37.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 62 | $13,454 | $5,975 | 44.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 68 | 107 | $8,988 | $4,477 | 49.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 49 | 49 | $10,633 | $4,063 | 38.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $6,012 | $2,105 | 35.0% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 16 | 17 | $3,111 | $1,169 | 37.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 418 | 2,679 | $391,134 | $148,612 | 38.0% |
About Dr. Serge Lartchenko, MD
Dr. Serge Lartchenko, MD is a Specialist healthcare provider based in Richardson, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1992787089.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Serge Lartchenko, MD has received a total of $8,542 in payments from pharmaceutical and medical device companies, with $817.38 received in 2024. These payments were reported across 498 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($7,926).
As a Medicare-enrolled provider, Lartchenko has provided services to 5,370 Medicare beneficiaries, totaling 16,177 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Infectious Disease, Infectious Disease
- Location Richardson, TX
- Active Since 11/15/2005
- Last Updated 04/14/2020
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1992787089
Products in Payments
- SYMTUZA (Drug) $1,276
- DOVATO (Drug) $1,007
- PREZCOBIX (Drug) $499.55
- Arikayce (Drug) $408.84
- ISENTRESS (Drug) $384.19
- ZERBAXA (Drug) $373.79
- EGRIFTA (Drug) $342.30
- Symtuza (Drug) $312.27
- PIFELTRO (Drug) $228.32
- MRI Ready Leads (Device) $157.46
- DELSTRIGO (Drug) $152.88
- JULUCA (Drug) $150.27
- TRIUMEQ (Drug) $148.97
- DORYX (Drug) $134.95
- AVYCAZ (Drug) $132.04
- Baxdela (Drug) $129.36
- DIFICID (Drug) $126.77
- Vibativ (Drug) $124.25
- TROGARZO (Drug) $123.57
- VIBATIV (Drug) $119.46
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Richardson
Dr. Arif Khan
Specialist — Payments: $4,591
Specialist $4,591
Dr. Carol Norton, M.d, M.D
Specialist — Payments: $1,508
Specialist $1,508
Dr. Mark Jaffe, Md, MD
Specialist — Payments: $803.77
Specialist $803.77
Thomas Frank, M.d, M.D
Specialist — Payments: $760.31
Specialist $760.31
Aralis Santiago-Plaud, Md, MD
Specialist — Payments: $669.99
Specialist $669.99
Dr. John Porter, M.d, M.D
Specialist — Payments: $379.97
Specialist $379.97